Opposing roles for two enzymes in heart failure

October 10, 2018, Tohoku University
Opposite roles for ROCK1 and ROCK2 in Pulmonary hypertension with heart failure in mice. Credit: Tohoku University

Investigations in mice have identified molecular processes that could be explored as targets for treatment of heart failure with pulmonary hypertension.

Two related enzymes have opposing roles in mouse exposed to pressure overload, according to a recent study published in the Proceedings of the National Academy of Sciences, USA. This finding furthers understanding of pulmonary hypertension that has developed as a result of .

Heart failure affects an estimated 26 million people worldwide. It is a condition in which the 's muscular wall becomes weak and unable to efficiently pump blood into the general circulation. This causes a build-up of blood, and thus pressure, in the heart's chambers. This leads to further damage and build-up of blood pressure within the vessels entering and leaving the lungs, a condition known as pulmonary hypertension.

Understanding the molecular changes that occur during this process could lead to the development of drugs that improve heart failure with pulmonary hypertension.

A team of scientists at Tohoku University in Japan investigated the roles of two molecules, ROCK1 and ROCK2, in heart failure with pulmonary hypertension. The molecules belong to a family of enzymes known for their roles in cellular functions such as contraction, motility, proliferation and natural cell death.

The scientists generated two types of mice in which the genes that code for ROCK1 or ROCK2 in cardiac muscle cells were turned off. Then, they constricted the ascending part of the aorta, the main vessel that leaves the left ventricle of the heart and distributes blood to the rest of the body. This caused chronic pressure overload and thus heart failure. For comparison, the team also restricted the ascending aorta in a control group of wild-type mice with normal levels of ROCK1 and ROCK2 in their .

They found that ROCK1 has a protective effect on heart failure with pulmonary through its role in decreasing the expression of cyclophilin A and basigin, proteins that increase oxidative stress in cells, which leads to their dysfunction. ROCK2, on the other hand, had a harmful effect by increasing the expression of the two proteins.

The team combed through compound databases to look for potential drugs that could target the ROCK2 pathway. They found that a chemical, called celastrol, suppresses the expression of cyclophilin A and basigin in the heart and lungs. Celastrol has been reported to have beneficial effects in some inflammatory conditions like rheumatoid arthritis. Suppressing cyclophilin A and basigin with celastrol in the mice improved their heart failure and .

Further studies are needed to identify celastrol's molecular and cellular targets and thus its potential in the treatment of heart , the researchers conclude.

Explore further: Study identifies new target for treatment of pulmonary hypertension

More information: Shinichiro Sunamura et al. Different roles of myocardial ROCK1 and ROCK2 in cardiac dysfunction and postcapillary pulmonary hypertension in mice, Proceedings of the National Academy of Sciences (2018). DOI: 10.1073/pnas.1721298115

Related Stories

Study identifies new target for treatment of pulmonary hypertension

April 30, 2018
Scientists at Stanley Manne Children's Research Institute at Ann & Robert H. Lurie Children's Hospital of Chicago have identified a gene called FoxM1 as a promising target for treatment of pulmonary hypertension, or high ...

What is heart failure?

April 17, 2018
Heart failure – one of the conditions former first lady Barbara Bush has been diagnosed with – is a fairly common condition, especially among older patients.

Pregnant Asian women who develop high blood pressure at highest risk for heart failure hospitalization

November 14, 2017
Women who develop high blood pressure during pregnancy are more likely to experience heart problems within a few years of giving birth, according to preliminary research presented at the American Heart Association's Scientific ...

Studies show exercise is safe, improves quality of life for pulmonary hypertension patients

September 2, 2015
Exercise training for patients with pulmonary hypertension was shown to be safe and to improve quality of life, according to an analysis by UT Southwestern Medical Center cardiologists of studies involving more than 400 participants.

Crosstalk between cells plays role in pulmonary hypertension

April 25, 2018
Pulmonary hypertension is a type of high blood pressure that affects blood vessels in the lungs. Once diagnosed, patients have limited treatment options, and many do not live beyond seven years. In a new study, scientists ...

Genetically-modified probiotic may one day treat pulmonary hypertension

September 16, 2016
An oral, genetically-modified strain of the probiotic Lactobacillus was used to treat rats with high blood pressure in the lungs, which resulted in reduced blood pressure, improved heart contractility, and reduced heart wall ...

Recommended for you

Exercise may be as effective as prescribed drugs to lower high blood pressure

December 18, 2018
Exercise may be as effective as prescribed drugs to lower high (140 mm Hg) blood pressure, suggests a pooled analysis of the available data, in what is thought to be the first study of its kind, and published online in the ...

Can stem cells help a diseased heart heal itself? Researchers achieve important milestone

December 14, 2018
A team of Rutgers scientists, including Leonard Lee and Shaohua Li, have taken an important step toward the goal of making diseased hearts heal themselves—a new model that would reduce the need for bypass surgery, heart ...

Your weight history may predict your heart failure risk

December 12, 2018
In a medical records analysis of information gathered on more than 6,000 people, Johns Hopkins Medicine researchers conclude that simply asking older adult patients about their weight history at ages 20 and 40 could provide ...

New understanding of mysterious 'hereditary swelling'

December 12, 2018
For the first time ever, biomedical researchers from Aarhus University, Denmark, report cellular defects that lead to a rare disease, hereditary angioedema (HAE), in which patients experience recurrent episodes of swelling ...

Age is the biggest risk for heart disease, but lifestyle and meds have impact

December 12, 2018
Of all the risk factors for heart disease, age is the strongest predictor of potential trouble.

Higher risk of heart attack on Christmas Eve

December 12, 2018
The risk of heart attack peaks at around 10pm on Christmas Eve, particularly for older and sicker people, most likely due to heightened emotional stress, finds a Swedish study in this week's Christmas issue of The BMJ.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.